Expora Therapeutics
PrivateLast Round
Grant
Dec 1, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Expora Therapeutics is a biotechnology company that develops oral bacterial extracellular vesicle disease-modifying immunotherapies for gastrointestinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Expora Therapeutics Comparables
Compare Expora Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MD Healthcare | 68% | |
| Delonix Bioworks | 63% | |
| Evox Therapeutics | 61% |
Expora Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 1, 2025 | ||||
| Grant | Feb 1, 2025 |
Expora Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University System of Maryland Launch Fund | Grant |
| TEDCO | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 251% MoM, from 93 to 326.
- Dec 1, 2025
Received funding from the University System of Maryland Launch Fund.
Expora Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Expora Therapeutics's valuation, stock price, and market status.
Is Expora Therapeutics a public or private company?
Expora Therapeutics is a private company.
What is the current stock price of Expora Therapeutics?
Expora Therapeutics is a private company, so its shares have no public market price. Caplight tracks Expora Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Expora Therapeutics worth (valuation)?
Valuation information for Expora Therapeutics is not publicly available.
Can I buy Expora Therapeutics stock?
Expora Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Expora Therapeutics's last funding round?
Expora Therapeutics's most recent funding round was Grant on December 1, 2025.
Who are the main investors in Expora Therapeutics?
Key investors in Expora Therapeutics include University System of Maryland Launch Fund, TEDCO.
Will Expora Therapeutics IPO soon?
No public IPO plans have been announced for Expora Therapeutics.
How can I track Expora Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Expora Therapeutics's shares on secondary markets.